TOT BIOPHARM is a biopharmaceutical company that develops oncology drugs and therapies. It provides technology platforms anti-tumor drug candidates, which include monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), oncolytic virus products, and specialty oncology drugs such as liposome drugs, targeting various types of cancers.